Patent Law Weblog
recent posts
- Apple v. Squires: USPTO Director Has Unlimited Discretion on IPR Institution
- The Ghost in the Machine: Why GenAI Can Be Both a Brilliant Researcher and a Terrible Advocate
- Bayer Files Suit Against Trio of COVID-19 Vaccine Makers
- Allen v. Cooper (4th Cir. 2026)
- To Require an Inventor ID, or Not to Require an Inventor ID – That Is the Question
about
Month: January 2015
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "After Teva: How Will Patent Litigation Change?" on February 5, 2015 beginning at 2:00 pm (ET). Paul Berghoff of McDonnell Boehnen Hulbert & Berghoff LLP, Andrei Iancu of Irell & Manella LLP, and Kevin Rhodes of 3M Innovative Properties Co. will untangle the…
-
Strafford will be offering a webinar/teleconference entitled "Overcoming Sect. 101 Rejections Post-Alice Corp. — Leveraging USPTO Guidance and Recent Decisions to Meet Sect. 101 Patent Eligibility Requirements" on February 12, 2015 from 1:00 to 2:30 pm (EST). Charles Bieneman of Bejin Bieneman; Denise M. Kettelberger, Ph.D., of Sunstein Kann Murphy & Timbers; and Katherine M.…
-
By Kevin E. Noonan — Last week, what is described as "a broad coalition" representing patent holders and inventors sent a letter to Representatives Bob Goodlatte (VA, 6th) and John Conyers (MI, 13th), Chairman and Ranking Member, respectively, of the House Judiciary Committee; and Senators Chuck Grassley (R-IA) and Patrick Leahy (D-VT), Chairman and Ranking…
-
By Kevin E. Noonan — One of the frustrations for participants in the patent wars of the early 21st Century has been the failure of many of the most vulnerable stakeholders to take a stand against overreaching proposals by proponents of a crisis atmosphere in patent enforcement (such as the Goodlatte bill, H.R. 3309, ironically…
-
By Michael Borella — On January 27, the USPTO provided its promised set of examples of patent-eligible and patent-ineligible claims relating to the abstract idea exception to 35 U.S.C. § 101, in light of Alice Corp. v. CLS Bank. These examples are intended to be used in conjunction with the Office's 2014 Interim Guidance on…
-
By Kevin E. Noonan — In the aftermath of the Supreme Court's decision in AMP v. Myriad Genetics in 2013, Myriad (paradoxically to those either not paying attention or who over interpreted the scope of the Court's holding in its opinion) filed suit against six genetic diagnostic test providers (Ambry Genetics, Gene-by-Gene, Quest, GeneDx, Invitae,…
-
By Kevin E. Noonan — The phylogenetic Order Diptera comprises the "true" flies (defined as having a single pair of wings arising from the thorax) and is first found in the fossil record in the Middle Triassic (~245 million years ago). It is one of the most evolutionarily successful, comprising 120,000 known species and thought…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Tris Pharma Inc. v. Par Pharmaceutical Inc. et al.1:15-cv-00068; filed January 21, 2015 in the District Court of Delaware • Plaintiff: Tris Pharma Inc.• Defendants: Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. Infringement of…
-
January 29, 2015 – "IPR Defense: An Overview of Strategic Considerations and Potential Pitfalls From the Patent Owner's Perspective" (American Bar Association Center for Professional Development and Section of Intellectual Property Law) – 1:00 to 2:30 pm (ET) January 29, 2015 – "Combating Patent Trolls: Third-Party Solutions and Defense Strategies in Post-Grant and Litigation —…
-
Strafford will be offering a webinar/teleconference entitled "Coordinating Post-Grant Patent Opposition in Europe and the U.S. — Navigating Timing, Grounds for Opposition, Discovery, and Amendments to Maximize Protection in Both Jurisdictions" on February 26, 2015 from 1:00 to 2:30 pm (EST). Michael J. Flibbert and Leythem A. Wall of Finnegan Henderson Farabow Garrett & Dunner…
Patent Docs 